Vidipha Central Pharmaceutical Dividends and Buybacks
Dividend criteria checks 1/6
Vidipha Central Pharmaceutical is a dividend paying company with a current yield of 5.95%.
Key information
6.0%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if VDP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VDP's dividend payments have been increasing.
Dividend Yield vs Market
Vidipha Central Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (VDP) | 6.0% |
Market Bottom 25% (VN) | 3.4% |
Market Top 25% (VN) | 8.2% |
Industry Average (Pharmaceuticals) | 4.6% |
Analyst forecast (VDP) (up to 3 years) | n/a |
Notable Dividend: VDP's dividend (5.95%) is higher than the bottom 25% of dividend payers in the VN market (3.44%).
High Dividend: VDP's dividend (5.95%) is low compared to the top 25% of dividend payers in the VN market (8.35%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate VDP's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as VDP has not reported any payouts.